As expected, the expression of cancer-related genes in CTCs increased as the stage of prostate cancer advanced and, interestingly, no genes were detected with the AdnaTest in patients with primary prostate cancer, except for CD45. The gene discussed is PTPRC; the disease is prostate carcinoma.